BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3366621)

  • 1. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
    Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
    Kroesbergen J; Gelsema WJ; De Ligny CL
    Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K; Aigner S; Bühler M; Umbach I
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of iron-dextran on the biodistribution of technetium pyrophosphate.
    Choy D; Maddalena DJ; Murray IP
    Int J Nucl Med Biol; 1982; 9(4):277-82. PubMed ID: 7186499
    [No Abstract]   [Full Text] [Related]  

  • 7. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
    Kroesbergen J; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic significance of electrocardiography and myocardial scintigraphy with 99m Tc-Sn-pyrophosphate and 99m Tc-Sn-phosphone in patients with stenocardia].
    Zudbinov IuI; Ponomareva AG; Sokolov OK
    Med Radiol (Mosk); 1986 Aug; 31(8):22-6. PubMed ID: 3091990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of methods of myocardial scintigraphy using 99mTc-Sn-glucohepatonate and 99mTc-Sn-pyrophosphate in the diagnosis of acute myocardial infarction and unstable stenocardia].
    Stepanova IP; Malyshev IuM
    Kardiologiia; 1984 Mar; 24(3):31-5. PubMed ID: 6727090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial 99mTc-pyrophosphate scintigraphy in acute heart infarct].
    Hole T; Rokkones T
    Tidsskr Nor Laegeforen; 1990 Feb; 110(5):596-7. PubMed ID: 2309208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accumulation of 99m Tc-Sn-pyrophosphate in the myocardium and the contractile function of the left ventricle in patients with stable angina].
    Botnar' VI; Ostroumov EN
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):94-6. PubMed ID: 6639765
    [No Abstract]   [Full Text] [Related]  

  • 12. 99mTc bone scanning agents--V. Influence of experimental conditions on the labeling efficiency and gel chromatography of 99mTc(Sn)HMDP.
    Kroesbergen J; Wortelboer MR; Rijnsent A; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1987; 14(1):37-41. PubMed ID: 3583753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic aspects of the interaction of 99mTc in association with stannous pyrophosphate with damaged red blood cells.
    Billinghurst MW; Waddell TL
    Int J Appl Radiat Isot; 1983 Mar; 34(3):607-12. PubMed ID: 6303965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
    Tada A; Bungyo H; Hisada K
    Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic importance of a positive test of myocardial 99mTc-Sn-pyrophosphate accumulation in patients with stable stenocardia].
    Botnar' VI; Eventov AZ; Lupanov VP
    Kardiologiia; 1983 May; 23(5):44-6. PubMed ID: 6876546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional scintimetry in scaphoid fractures.
    Olsen N; Schousen P; Dirksen H; Christoffersen JK
    Acta Orthop Scand; 1983 Jun; 54(3):380-2. PubMed ID: 6858656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective use of stannous pyrophosphate.
    Sands M; Owunwanne A
    J Nucl Med; 1981 Oct; 22(10):932. PubMed ID: 7288493
    [No Abstract]   [Full Text] [Related]  

  • 18. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can myocardial ischemia be imaged with technetium-99m-Sn-2+-pyrophosphate?
    Bianco JA
    Circulation; 1982 Mar; 65(3):642-3. PubMed ID: 7055888
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyrophosphate scanning in early frostbite injury.
    Purdue GF; Lewis SA; Hunt JL
    Am Surg; 1983 Nov; 49(11):619-20. PubMed ID: 6638703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.